Diversified Healthcare Trust (DHC) EBITDA (2009 - 2026)

Diversified Healthcare Trust has reported EBITDA for 18 years, with the latest figure at -$3.9 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA rose 90.72% year-over-year to -$3.9 million; the trailing twelve-month figure through Mar 2026 stood at -$199.2 million (down 56.24% YoY), and the FY2025 full-year result was -$261.1 million, down 63.45% from the prior year.
• EBITDA for Q1 2026 stood at -$3.9 million, up from -$30.3 million in the prior quarter.
• The five-year high for EBITDA was $352.9 million in Q1 2022, with the low at -$113.7 million in Q3 2025.
• Historically, EBITDA has averaged $19.7 million across 5 years, with a median of $13.6 million in 2024.
• Annual changes were most pronounced in 2023 — EBITDA soared 3913.78% — and 2025, when it tumbled 934.66%.
• Diversified Healthcare Trust's EBITDA stood at $49.9 million in 2022, then rose by 5.49% to $52.6 million in 2023, then sank by 266.79% to -$87.7 million in 2024, then surged by 65.45% to -$30.3 million in 2025, then soared by 87.2% to -$3.9 million in 2026.
• The last three EBITDA figures came in at -$3.9 million (Q1 2026), -$30.3 million (Q4 2025), and -$113.7 million (Q3 2025), per Business Quant data.